France 2030 logo

France 2030

Europe, Rhone-Alpes, France, Villeurbanne

Description

France 2030 is a monumental French government investment plan, not a traditional venture capital firm, designed to strategically transform key sectors of the French economy. Launched in October 2021, the program initially committed €30 billion, which was subsequently increased to a substantial €54 billion (approximately $58.3 billion USD). This ambitious initiative aims to accelerate France's reindustrialization, drive the ecological transition, and foster innovation across critical domains, positioning the nation as a leader in future technologies and industries.

The plan targets ten strategic objectives, including the decarbonization of industry, the production of green hydrogen, the development of next-generation nuclear reactors, the manufacturing of electric vehicles, and advancements in bio-drugs, space, and deep-sea exploration. It seeks to bolster France's sovereignty and competitiveness by investing in cutting-edge research, industrial scale-ups, and the development of new skills. The program is primarily managed by public operators such as Bpifrance, ADEME, and the National Research Agency (ANR), which oversee various calls for projects and funding mechanisms.

Funding under France 2030 is diverse, encompassing grants, repayable advances, and, in some cases, equity investments. Unlike a typical venture capital fund with defined investment rounds, France 2030 supports a wide spectrum of beneficiaries, from startups and small and medium-sized enterprises (SMEs) to large industrial groups and research institutions. Consequently, the "check sizes" vary significantly based on the project's nature, scale, and strategic importance. For instance, smaller innovation projects or feasibility studies for SMEs can receive funding starting from approximately $200,000 USD, while major industrial initiatives, such as the construction of gigafactories or large-scale hydrogen production facilities, can secure over $100 million USD in public support.

Overall, France 2030 represents a comprehensive national strategy to build a more resilient, innovative, and environmentally sustainable economy. Its broad scope and substantial financial commitment underscore the French government's dedication to fostering long-term growth and addressing global challenges through strategic public investment in key future industries.

Investor Profile

France 2030 has backed more than 38 startups, with 14 new investments in the last 12 months alone. The firm has led 23 rounds, about 61% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Seed, Debt Financing rounds (top funding stages).
  • Majority of deals are located in France, The Netherlands, United States.
  • Strong thematic focus on Biotechnology, Manufacturing, Health Care.
  • Led 11 rounds in the past year.
  • Typical check size: $200K – $100M.

Stage Focus

  • Grant (68%)
  • Seed (8%)
  • Debt Financing (8%)
  • Series Unknown (5%)
  • Series A (5%)
  • Series B (3%)
  • Post Ipo Debt (3%)

Country Focus

  • France (95%)
  • The Netherlands (3%)
  • United States (3%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Health Care
  • Medical
  • Biopharma
  • Pharmaceutical
  • Semiconductor
  • Medical Device
  • Energy
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does France 2030 frequently co-invest with?

European Commission
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Starquest Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 2
BV
North America, California, United States, Berkeley
Co-Investments: 1
Groupe IDEC
Europe, Ile-de-France, France, Paris
Co-Investments: 2
EIC Accelerator
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Quantonation
Europe, Ile-de-France, France, Paris
Co-Investments: 2
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 6
Crédit Agricole
Europe, Ile-de-France, France, Montrouge
Co-Investments: 2
EIT InnoEnergy
Europe, Noord-Brabant, The Netherlands, Eindhoven
Co-Investments: 2

What are some of recent deals done by France 2030?

360Learning

New York, New York, United States

360Learning develops a collaborative learning solution to help companies unlock learning based on collective expertise.

B2BCorporate TrainingE-LearningEdTechHuman ResourcesProductivity ToolsSaaS
GrantJul 24, 2025
Amount Raised: $2,119,305
Dillico

Meylan, Rhone-Alpes, France

Dillico is a deep technology business that is developing new equipment to simplify and improve the production of mRNA vaccines & medicines.

Health Care
GrantJul 9, 2025
Amount Raised: $2,817,722
Ciloa

Montpellier, Languedoc-Roussillon, France

Ciloa is a uniquely positioned to support your projects aiming to create new therapeutic.

LegalMedicalTherapeutics
GrantJul 8, 2025
Amount Raised: $7,641,602
SiPearl

Maisons-laffitte, Ile-de-France, France

SiPearl designs European high-performance energy-efficient processors for supercomputing and AI

HardwareNetwork HardwareSemiconductor
Series AJul 8, 2025
Amount Raised: $37,620,194
cosma

Nice, Provence-Alpes-Cote d'Azur, France

cosma is a multi-disciplinary expertise in underwater robotics, navigation and data collection at sea, as well as data science.

Environmental Consulting
GrantJun 30, 2025
ATAWEY

Le Bourget-du-lac, Rhone-Alpes, France

ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites.

EnergyEnergy EfficiencyManufacturing
Series UnknownJun 27, 2025
Amount Raised: $25,785,279
Quobly

Grenoble, Rhone-Alpes, France

Quobly create and market a universal large-scale quantum computer, using tried-and-true semiconductor industry procedures.

Information TechnologyQuantum ComputingSemiconductor
GrantMay 22, 2025
Amount Raised: $16,922,898
OSE Immunotherapeutics

Nantes, Pays de la Loire, France

OSE Immunotherapeutics is an integrated biotechnology company focused on inflammatory disease and cancer treatment.

BiotechnologyMedicalMedical DeviceOncologyPharmaceutical
GrantMay 21, 2025
Amount Raised: $1,473,303
Eligo Bioscience

Paris, Ile-de-France, France

Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.

BiotechnologyHealth CareMedical
GrantMay 13, 2025
Amount Raised: $5,000,000
Chipiron

Paris, Ile-de-France, France

Chipiron is a company that designs, manufactures, and markets a new generation of portable, inexpensive and powerful MRI machines.

Emergency MedicineHealth CareHealth DiagnosticsHome Health CareManufacturingMedicalMedical DevicePersonal Health
Series AApr 30, 2025
Amount Raised: $17,000,000